Somatic rearrangements causing oncogenic ectodomain deletions of FGFR1 in squamous cell lung cancer
The discovery of frequent 8p11-p12 amplifications in squamous cell lung cancer (SQLC) has fueled hopes that FGFR1, located inside this amplicon, might be a therapeutic target. In a clinical trial, only 11% of patients with 8p11 amplification (detected by FISH) responded to FGFR kinase inhibitor trea...
Main Authors: | Florian Malchers, Lucia Nogova, Martijn H.A. van Attekum, Lukas Maas, Johannes Brägelmann, Christoph Bartenhagen, Luc Girard, Graziella Bosco, Ilona Dahmen, Sebastian Michels, Clare E. Weeden, Andreas H. Scheel, Lydia Meder, Kristina Golfmann, Philipp Schuldt, Janna Siemanowski, Jan Rehker, Sabine Merkelbach-Bruse, Roopika Menon, Oliver Gautschi, Johannes M. Heuckmann, Elisabeth Brambilla, Marie-Liesse Asselin-Labat, Thorsten Persigehl, John D. Minna, Henning Walczak, Roland T. Ullrich, Matthias Fischer, Hans Christian Reinhardt, Jürgen Wolf, Reinhard Büttner, Martin Peifer, Julie George, Roman K. Thomas |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Clinical Investigation
2023-11-01
|
Series: | The Journal of Clinical Investigation |
Subjects: | |
Online Access: | https://doi.org/10.1172/JCI170217 |
Similar Items
-
Biomarkers for Homologous Recombination Deficiency in Cancer
by: Svenja Wagener-Ryczek, et al.
Published: (2021-06-01) -
Adult lung stem cells and their contribution to lung tumourigenesis
by: Marie-Liesse Asselin-Labat, et al.
Published: (2012-01-01) -
Lung Basal Stem Cells Rapidly Repair DNA Damage Using the Error-Prone Nonhomologous End-Joining Pathway.
by: Clare E Weeden, et al.
Published: (2017-01-01) -
Clonal dynamics of BRAF-driven drug resistance in EGFR-mutant lung cancer
by: Diana Schaufler, et al.
Published: (2021-12-01) -
ALK G1269A mutation as a potential mechanism of acquired resistance to crizotinib in an ALK-rearranged inflammatory myofibroblastic tumor
by: Sebastian Y. F. Michels, et al.
Published: (2017-03-01)